Stock Market News2 weeks Amgen Stock Falls 12% in a Month: Should You Buy the Dip? Zacks
AMGN’s reasonable valuation, an interesting pipeline and continued top-line growth are good enough reasons to stay invested in the stock for now.
X21 hours Amgen (AMGN) Stock Moves -0.21%: What You Should Know Zacks
X2 days Viridian Stock Flashes A Bullish Sign In Its Eye-Disease Battle With Amgen Investor's Business Daily
X6 days Why Amgen (AMGN) is a Top Growth Stock for the Long-Term Zacks
X7 days Amgen (AMGN) Stock Sinks As Market Gains: Here’s Why Zacks
X1 week Here’s Why Amgen (AMGN) is a Strong Value Stock Zacks
X1 week Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock Zacks
X1 week The Zacks Analyst Blog Eli Lilly, Novo Nordisk’s Amgen and Viking Therapeutics Zacks
X2 weeks Johnson & Johnson Is A Better Dividend Stock Than Amgen In Our View Seeking Alpha
X2 weeks The Zacks Analyst Blog Highlights Amgen, Eaton, Sony, iMage and Enzo Biochem Zacks
X2 weeks Top Stock Reports for Amgen, Eaton & Enzo Biochem Zacks
X2 weeks Amgen Inc. (AMGN) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript) Seeking Alpha
X3 weeks Eli Lilly and Novo Nordisk’s Obesity Moat Just Got Stronger The Wall Street Journal
X3 weeks Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know Zacks
X3 weeks Is Amgen Stock Still a Buy After an Unexpected Reveal of Data? Yahoo Finance
X3 weeks AMGN Stock Down Despite Strong Data From Obesity Drug Study Zacks
X3 weeks Amgen’s Phase 2 Results Were Not Bad, Don’t Let Mr. Market Fool You Seeking Alpha
X3 weeks Amgen: Checks All The Wrong Boxes Seeking Alpha
X3 weeks Final Trade: JWN, IWM, GCO, AMGN YouTube
X3 weeks Wait for longer-term data with Amgen’s GLP-1, says Piper Sandler’s Christopher Raymond YouTube
X3 weeks Amgen stock sinks as weightloss drug fails to impress FXStreet
X3 weeks Amgen: MariTide Underwhelms, But There Are Ways To Win Seeking Alpha
X3 weeks Chart of the Day: Amgen YouTube
X3 weeks Cramer’s Stop Trading: Amgen YouTube
X3 weeks Amgen Stock Dives After Weight-Loss Drug Data. Here’s What to Know. Yahoo Finance
X3 weeks Amgen Dives 5% Despite ‘Truly Remarkable’ Results For Obesity Treatment Investor's Business Daily
X3 weeks Amgen Stock Dives Despite Positive Weight-Loss Drug Data. What to Know. Yahoo Finance
X3 weeks Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau YouTube
X3 weeks These Stocks Are Moving the Most Today: GM, Ford, Amgen, Eli Lilly, Super Micro, Best Buy, Analog Devices, Kohl’s, Semtech, and More Yahoo Finance
X4 weeks Why Amgen (AMGN) is a Top Value Stock for the Long-Term Zacks
X1 month Amgen Sells Off: Keep Calm And Buy The Dip Seeking Alpha
X1 month Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It Zacks
X1 month Amgen, Merck stocks dive as Trump picks anti-vaxxer RFK Jr. to lead US healthcare FXStreet
X1 month Amgen Shrugs Off Bone Density Concerns Related to Obesity Candidate Zacks
X1 month Amgen Inc. (AMGN) UBS Global Healthcare Conference (Transcript) Seeking Alpha
X1 month Trade Tracker: Joe Terranova sells Amgen and buys XBI YouTube
X1 month Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand? Investor's Business Daily
X1 month Amgen dismisses bone density concerns related to its new weight-loss drug Investing.com
X1 month Amgen sinks as Cantor flags issues with obesity drug YouTube
X1 month Amgen stock falls as analysts mull over weight loss drug’s bone density data CNBC
X1 month Amgen Drops 7% After A ‘Big Unknown Risk’ Rattles Its Monthly Obesity Shot Investor's Business Daily
X1 month Big Pharma’s Obesity Bonanza Faces New Tests The Wall Street Journal
X2 months Amgen: A Biotech Giant Offering Value And Growth In A Frothy Market Seeking Alpha
X2 months Analyst Report: AMGEN Inc. Yahoo Finance
X2 months Market Digest: AAPL, AMGN, AMP, BBY, CTSH, EPD, MCO, UNP, MA, VRSK, PPC, GEHC Yahoo Finance
X2 months Amgen Inc. (AMGN) Q3 2024 Earnings Call Transcript Seeking Alpha
X2 months Amgen Inc. 2024 Q3 – Results – Earnings Call Presentation Seeking Alpha
X2 months Amgen ‘Laser-Focused’ On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFO Investor's Business Daily
X2 months Amgen beats Q3 earnings estimates, raises full-year guidance Investing.com
X2 months Pfizer Unveils Its Next Black Box In Obesity. It’s Taking On Amgen. Investor's Business Daily
X2 months First American Bank Has $4.18 Million Stake in Amgen Inc. (NASDAQ:AMGN) MarketBeat
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.